MindMed Psychedelic Medicines Pipeline 2020

MindMed presents its diversified pipeline of psychedelic-inspired medicines in clinical development and research, including LSD-assisted therapy, 18-MC, and programs targeting opioid withdrawal, anxiety, and ADHD. The company outlines its clinical trial progress across multiple phases and R&D initiatives spanning LSD, MDMA, DMT, and psilocybin compounds.